Apr 14, 2021 (Stock Traders Daily via COMTEX) -- This Integra Lifesciences Hldg /zigman2/quotes/200866868/composite IART -0.83% report helps investors and traders identify both opportunity, and potential red flags, by using the price action of the stock. The trading plans for IART have risk controls, and that make these observations both opportunistic and defensive, but the data on this page is not real time. If you want a real time update, or a different stock, please get one here Unlimited Real Time Reports .
The Technical Summary and Trading Plans for IART help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this IART Report.
The technical summary data tells us to buy IART near 66.52 with an upside target of 73.55. This data also tells us to set a stop loss @ 66.33 to protect against excessive loss in case the stock begins to move against the trade. 66.52 is the first level of support below 70.22 , and by rule, any test of support is a buy signal. In this case, support 66.52 is being tested, a buy signal would exist.
The technical summary data is suggesting a short of IART as it gets near 73.55 with a downside target of 66.52. We should have a stop loss in place at 73.76though. 73.55 is the first level of resistance above 70.22, and by rule, any test of resistance is a short signal. In this case, if resistance 73.55 is being tested, a short signal would exist.
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.